Independent Board Director
Company Description: A Seed-stage public benefit corporation focused on a next generation of safer, gentler, more accessible MDMA-like medicines. Progress to date includes six awarded US patents. Current focus is advancing a new chemical entity into clinical trials.
Target Candidate Industry: Current or Former Executive Role in Health, Business Development, Mental Health, Healthcare